Barriers to orphan drug development
This is the second in a series of articles aiming to highlight the vital role that drug development consultants play in helping small pharma companies to bring new medicines to the market. To put this properly into context, it is essential to understand the barriers currently restricting the development of new medicines for very rare […]
